Stay updated with breaking news from Christopherj Senner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
William Blair restated their outperform rating on shares of Exelixis (NASDAQ:EXEL – Free Report) in a research report report published on Monday morning, RTT News reports. William Blair also issued estimates for Exelixis’ Q3 2023 earnings at ($0.05) EPS and FY2023 earnings at $0.45 EPS. EXEL has been the topic of several other research reports. […]
Creative Planning decreased its position in Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 10.8% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 86,312 shares of the biotechnology company’s stock after selling 10,419 shares during the period. Creative Planning’s holdings in Exelixis were worth […]
Capital Management Corp VA boosted its position in shares of Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 2.7% during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund owned 363,354 shares of the biotechnology company’s stock after purchasing an additional 9,539 shares during the quarter. Capital Management Corp VA’s […]
Exelixis, Inc. (NASDAQ:EXEL – Get Free Report) was the target of a large growth in short interest during the month of September. As of September 15th, there was short interest totalling 8,400,000 shares, a growth of 6.6% from the August 31st total of 7,880,000 shares. Based on an average daily trading volume, of 2,230,000 shares, […]
HC Wainwright began coverage on shares of Exelixis (NASDAQ:EXEL – Free Report) in a report issued on Tuesday morning, MarketBeat reports. The brokerage issued a buy rating and a $28.00 target price on the biotechnology company’s stock. A number of other equities analysts have also commented on the stock. Barclays cut their price objective on […]